| D-0474-2026 | Class II | Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Cover | March 19, 2026 |
| D-0472-2026 | Class II | Clonidine Transdermal System, USP, 0.1 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Cover | March 19, 2026 |
| D-0473-2026 | Class II | Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Cover | March 19, 2026 |
| D-0405-2026 | Class II | Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 20 mg, Single-dose 8 mL | March 17, 2026 |
| D-0404-2026 | Class II | Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 10 mg, Single-dose 8 mL | March 17, 2026 |
| D-0406-2026 | Class II | Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, Single-dose 8 mL | March 17, 2026 |
| D-0355-2026 | Class II | Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (NDC: 45963-676-11) and 1, | January 29, 2026 |
| D-0357-2026 | Class II | Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceut | January 29, 2026 |
| D-0356-2026 | Class II | Metoprolol Succinate Extended-Release Tablets, Rx Only, 100 mg, 100 tablets bottles (NDC: 45963-677- | January 29, 2026 |
| D-0354-2026 | Class II | Metoprolol Succinate Extended-Release Tablets, 25 mg, 100 tablets bottles (NDC: 45963-709-11) and 1, | January 29, 2026 |
| D-0445-2026 | Class II | Isotretinoin Capsules, USP, 30 mg, Rx Only, 10 count Prescription Pack, Manufactured for: Teva Pharm | January 12, 2026 |
| D-0446-2026 | Class II | Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Pharm | January 12, 2026 |
| D-0198-2026 | Class III | Carton label: Testosterone Gel 1%, 2.5 grams per unit dose, CIII, 30 unit-dose packets, Rx only, Man | November 7, 2025 |
| D-0151-2026 | Class II | Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when | October 13, 2025 |
| D-0105-2026 | Class II | Prazosin Hydrochloride, Capsules, USP, 2 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, INC., | October 7, 2025 |
| D-0104-2026 | Class II | Prazosin Hydrochloride, Capsules, USP, 1 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, INC., | October 7, 2025 |
| D-0106-2026 | Class II | Prazosin Hydrochloride, Capsules, USP, 5 mg, Rx only, Distributed by TEVA PHARMACEUTICALS USA, INC., | October 7, 2025 |
| D-0473-2025 | Class II | Metoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Croatia by Pliva Hrvat | May 23, 2025 |
| D-0218-2025 | Class II | Granix (tbo-filgrastim) Injection 300 mcg/0.5 mL, Single Dose prefilled syringe, packaged as a) 1 sy | January 10, 2025 |
| D-0637-2024 | Class II | Testosterone Gel, 1.62%, (Alcohol 80% v/v), 30 unit-dose packets, Rx Only, Teva Pharmaceuticals, USA | August 8, 2024 |